A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer.

Wu, Qing; Tao, Xuan; Luo, Yang; Zheng, Shiyao; Lin, Nan; Xie, Xianhe

Wu, Qing; Tao, Xuan; Luo, Yang; Zheng, Shiyao; Lin, Nan; Xie, Xianhe.

Afiliación

Wu Q; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, China.
Tao X; Department of Oncology, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
Luo Y; Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Zheng S; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, China.
Lin N; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, Fujian, China.
Xie X; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.

BMC Cancer ; 23(1): 776, 2023 Aug 18.

Article en En | MEDLINE | ID: mdl-37596527

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Neoplasias de la Mama/genética; Secuencias Reguladoras de Ácidos Nucleicos; Pronóstico; Linfocitos T CD8-positivos; Calibración; Microambiente Tumoral/genética

Palabras clave

Breast cancer; Immune checkpoints; Overall survival; Super-enhancer; Tumor immune microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google